| Recruiting | iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight NCT07237750 | Liu Yan | N/A |
| Not Yet Recruiting | Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis NCT02933554 | Keith Pereira, MD: | N/A |
| Recruiting | The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health NCT07093346 | University of Nottingham | N/A |
| Recruiting | Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases NCT07248371 | Chang Gung Memorial Hospital | — |
| Recruiting | To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Dise NCT07149571 | Tongji Hospital | — |
| Recruiting | Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAF NCT06564584 | OrsoBio, Inc | Phase 2 |
| Completed | Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MAS NCT06482112 | Merck Sharp & Dohme LLC | Phase 2 |
| Recruiting | Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD NCT06449833 | Zhujiang Hospital | Phase 4 |
| Unknown | Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines NCT06257732 | Yeditepe University | N/A |
| Recruiting | Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoh NCT06368882 | First Affiliated Hospital of Wenzhou Medical University | Phase 4 |
| Unknown | Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver Disease NCT06166797 | Massachusetts General Hospital | — |
| Withdrawn | A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria NCT06138327 | BioMarin Pharmaceutical | Phase 1 |
| Completed | A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6 NCT05877547 | Merck Sharp & Dohme LLC | Phase 2 |
| Active Not Recruiting | Phase 2b Study of GSK4532990 in Adults With NASH NCT05583344 | GlaxoSmithKline | Phase 2 |
| Recruiting | Gastric Bypass Stent Small-Sample-Size Study For Nonalcoholic Fatty Liver Disease NCT05495139 | Hangzhou Tangji Medical Technology Co., Ltd. | N/A |
| Terminated | Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US NCT05211284 | Zydus Therapeutics Inc. | Phase 2 |
| Recruiting | Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatit NCT05507151 | West Virginia University | — |
| Completed | Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Live NCT05560607 | AstraZeneca | Phase 1 |
| Completed | Vitamin E Dosing Study NCT04801849 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease NCT05497765 | Guangzhou Medical University | N/A |
| Completed | Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD) NCT05459701 | Rehab Werida | Phase 4 |
| Recruiting | Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease NCT05330923 | Peking Union Medical College Hospital | — |
| Recruiting | Observational Study About Patients Diagnosed With NAFLD NCT05625750 | Xiangya Hospital of Central South University | — |
| Completed | The University of Michigan Wellness for Liver Health Study NCT05010070 | University of Michigan | Phase 1 / Phase 2 |
| Completed | A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001 NCT04944992 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD )：a 12-month Follow-up Study NCT04988230 | Nanfang Hospital, Southern Medical University | N/A |
| Unknown | FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis NCT04710524 | Future Medicine | Phase 2 |
| Completed | Gut Microbiota in Chronic Noncommunicable Diseases NCT04820556 | National Medical Research Center for Therapy and Preventive Medicine | — |
| Unknown | Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout NCT04772352 | Ningbo No. 1 Hospital | Phase 2 |
| Terminated | A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic NCT04766476 | Bristol-Myers Squibb | Phase 1 |
| Unknown | Screening of NASH in Oupatients Followed in Various Hospital Specialty Clinics at the University Hospital of S NCT04282447 | University Hospital, Strasbourg, France | — |
| Completed | Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Pr NCT04399538 | Pfizer | Phase 2 |
| Completed | Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) NCT04321031 | Pfizer | Phase 2 |
| Completed | Comparison of Dietary Sugar Reduction Methods NCT04186793 | Emory University | N/A |
| Completed | Effect of Mediterranean Diet in Obese Adolescents With Nonalcoholic Fatty Liver Disease NCT04845373 | Gazi University | N/A |
| Completed | Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD NCT05523648 | Sichuan Leshan Traditional Chinese Medicine Hospital | EARLY_Phase 1 |
| Unknown | Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease NCT04369521 | National Nutrition and Food Technology Institute | N/A |
| Active Not Recruiting | Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease NCT04132440 | M.D. Anderson Cancer Center | — |
| Completed | Time Restricted Feeding on Nonalcoholic Fatty Liver Disease NCT03786523 | Nanfang Hospital, Southern Medical University | N/A |
| Completed | De Novo Lipogenesis in Severity of NAFLD NCT03683589 | University of Missouri-Columbia | — |
| Completed | The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NA NCT06044467 | ChemomAb Ltd. | Phase 1 |
| Completed | A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) NCT03656744 | HighTide Biopharma Pty Ltd | Phase 2 |
| Completed | Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease NCT04988204 | Icahn School of Medicine at Mount Sinai | N/A |
| Completed | An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels NCT03674476 | Bristol-Myers Squibb | Phase 1 |
| Completed | A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver Disease NCT03998514 | CohBar, Inc. | Phase 1 |
| Completed | Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepa NCT03434613 | Yonsei University | Phase 4 |
| Completed | Association Between Nonalcoholic Fatty Liver Disease and Acute Pancreatitis NCT03566173 | Ningbo No. 1 Hospital | — |
| Completed | A Study of Experimental Medication BMS-986036 Given to Healthy Participants NCT03445208 | Bristol-Myers Squibb | Phase 1 |
| Completed | Effectiveness of Exercise Applications on Hepatic Steatosis and Physical Fitness in Patients With NAFLD NCT03461562 | Okan University | N/A |
| Unknown | Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLD NCT03375580 | The First Affiliated Hospital of Guangdong Pharmaceutical University | N/A |
| Completed | Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese P NCT03366987 | Ningbo No. 1 Hospital | — |
| Completed | Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) NCT03248882 | Pfizer | Phase 2 |
| Completed | Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Tri NCT03774511 | Ahlia University | N/A |
| Completed | Effects of Fructose Restriction on Liver Steatosis NCT03067428 | Maastricht University Medical Center | N/A |
| Recruiting | Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease NCT02863757 | Humanity and Health Research Centre | — |
| Unknown | NASH: Non-invasive Diagnostic Markers and Imaging NCT02717000 | Maastricht University Medical Center | — |
| Completed | Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy NCT02684591 | University of California, San Diego | Phase 2 |
| Unknown | Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis NCT03386890 | Beijing Friendship Hospital | — |
| Completed | Dietary Treatment Study of Pediatric NAFLD NCT02513121 | University of California, San Diego | N/A |
| Recruiting | Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease NCT02422238 | Maastricht University Medical Center | — |
| Unknown | Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study NCT02469272 | Lifespan | Phase 1 |
| Completed | Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASH NCT02412540 | Children's Hospital Medical Center, Cincinnati | N/A |
| Completed | Fatty Liver Disease in Obese Children NCT02117700 | Nemours Children's Clinic | Phase 1 / Phase 2 |
| Recruiting | Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus NCT05697991 | King Saud University | — |
| Completed | Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease NCT02132780 | Virginia Commonwealth University | — |
| Completed | Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes NCT02132442 | University of Massachusetts, Worcester | Phase 3 |
| Completed | Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepat NCT01934777 | Bambino Gesù Hospital and Research Institute | Phase 3 |
| Completed | Purified Anthocyanin and Nonalcoholic Fatty Liver Disease NCT01940263 | Shaoguan University | EARLY_Phase 1 |
| Completed | Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease NCT01828528 | Sheba Medical Center | — |
| Terminated | Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoh NCT02029586 | Yungjin Pharm. Co., Ltd. | Phase 2 |
| Unknown | THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOS NCT01735799 | Assy Nimer | — |
| Completed | Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subjects With Features of Fatty Liv NCT01707914 | Shaoguan University | N/A |
| Completed | A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection NCT01645852 | Dartmouth-Hitchcock Medical Center | N/A |
| Completed | Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant Neoplasm NCT01657773 | Wenzhou Medical University | — |
| Completed | High Fructose Corn Syrup NCT02018237 | Washington University School of Medicine | N/A |
| Completed | Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease NCT01446276 | University of Aarhus | N/A |
| Completed | Dietary Protein and Hepatic Fat Accumulation NCT01354626 | Wageningen University | N/A |
| Terminated | Rifaximin in Fatty Liver Disease NCT01355575 | Imperial College London | Phase 4 |
| Completed | Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes NCT01399645 | Centre hospitalier de l'Université de Montréal (CHUM) | Phase 2 |
| Terminated | Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT) NCT01244503 | Virginia Commonwealth University | Phase 2 |
| Unknown | The Contribution of Lp-PLA2 Level to the Presence of Coronary Plaques in Patients With Non Alcoholic Fatty Liv NCT01139632 | Ziv Hospital | — |
| Completed | Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis NCT01210989 | Chinese University of Hong Kong | N/A |
| Completed | A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoria NCT00930384 | George Washington University | — |
| Enrolling By Invitation | Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD) NCT00983463 | Vanderbilt University | — |
| Completed | Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) NCT00885313 | Bambino Gesù Hospital and Research Institute | Phase 1 / Phase 2 |
| Completed | Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics NCT00870012 | Chinese University of Hong Kong | N/A |
| Completed | Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease NCT00868933 | Chinese University of Hong Kong | N/A |
| Completed | Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease NCT03847116 | Ningbo No. 1 Hospital | — |
| Completed | University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial NCT00994682 | University of Florida | Phase 4 |
| Completed | Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH) NCT01208649 | Ruhr University of Bochum | Phase 4 |
| Completed | Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease NCT00633282 | Xin Gao | Phase 2 |
| Completed | Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease NCT01006889 | University of Florida | Phase 4 |
| Unknown | Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in P NCT00658164 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Phase 3 |
| Terminated | Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study NCT00637520 | Duke University | — |
| Unknown | Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoh NCT00699036 | Brooke Army Medical Center | Phase 2 |
| Completed | Weight Gain After Smoking Cessation and NAFLD NCT05550688 | Ningbo No. 1 Hospital | — |
| Completed | Role of Exenatide in NASH-a Pilot Study NCT00650546 | Indiana University | Phase 2 / Phase 3 |
| Completed | LAGB as a Treatment for Morbid Obesity in Adolescents NCT01045499 | Jeffrey L Zitsman, MD | N/A |
| Completed | Fatty Acids, Genes and Microbiota in Fatty Liver NCT02148471 | Johane Allard | — |
| Completed | Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in NCT01084486 | Wolfson Medical Center | Phase 1 / Phase 2 |